Correlation Between Hookipa Pharma and AVROBIO

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and AVROBIO at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and AVROBIO into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and AVROBIO, you can compare the effects of market volatilities on Hookipa Pharma and AVROBIO and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of AVROBIO. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and AVROBIO.

Diversification Opportunities for Hookipa Pharma and AVROBIO

-0.64
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Hookipa and AVROBIO is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and AVROBIO in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AVROBIO and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with AVROBIO. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AVROBIO has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and AVROBIO go up and down completely randomly.

Pair Corralation between Hookipa Pharma and AVROBIO

Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the AVROBIO. In addition to that, Hookipa Pharma is 2.09 times more volatile than AVROBIO. It trades about -0.19 of its total potential returns per unit of risk. AVROBIO is currently generating about -0.13 per unit of volatility. If you would invest  145.00  in AVROBIO on September 3, 2024 and sell it today you would lose (5.00) from holding AVROBIO or give up 3.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy9.6%
ValuesDaily Returns

Hookipa Pharma  vs.  AVROBIO

 Performance 
       Timeline  
Hookipa Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hookipa Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
AVROBIO 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AVROBIO has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, AVROBIO is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Hookipa Pharma and AVROBIO Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hookipa Pharma and AVROBIO

The main advantage of trading using opposite Hookipa Pharma and AVROBIO positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, AVROBIO can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AVROBIO will offset losses from the drop in AVROBIO's long position.
The idea behind Hookipa Pharma and AVROBIO pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities